Table 2 Five-year relative survival of patients with multiple myeloma

Men

 Study population (15–79 years)

  Crude

33.6 (28.1–39.2)

47.6 (41.4–53.9)

57.5 (51.9–63.1)

59.4 (54.0–64.7)

  Age standardised

35.5 (29.8–41.3)

50.5 (44.5–56.6)

58.6 (53.0–64.1)

61.7 (56.5–66.8)

 15–69 yrs

39.9 (32.7–47.2)

59.5 (51.8–67.2)

61.4 (54.5–68.3)

67.6 (61.0–74.2)

 70–79 yrs

24.8 (16.0–33.6)

27.9 (18.3–37.5)

52.3 (42.8–61.8)

48.5 (39.9–57.1)

Women

 Study population

  Crude

33.5 (27.5–39.5)

49.5 (42.8–56.2)

53.4 (47.4–59.5)

59.9 (53.8–66.1)

  Age standardised

38.5 (32.5–44.4)

52.4 (45.6–59.2)

58.2 (52.5–63.9)

63.4 (57.4–69.3)

 15–69 yrs

41.8 (33.5–50.0)

56.0 (47.5–64.4)

62.0 (54.1–69.9)

71.2 (63.8–78.7)

 70–79 yrs

23.1 (14.9–31.3)

40.4 (29.8–51.0)

43.7 (34.7–52.6)

44.3 (34.6–54.0)

Both

 Study population

  Crude

33.5 (29.4–37.6)

48.5 (43.9–53.1)

55.6 (51.5–59.7)

59.6 (55.5–63.7)

  Age standardised

36.7 (32.5–40.9)

51.5 (46.9–56.1)

58.2 (54.2–62.3)

62.4 (58.5–66.3)

 15–69 yrs

40.7 (35.3–46.2)

57.9 (52.3–63.6)

61.6 (56.4–66.8)

69.2 (64.2–74.1)

 70–79 yrs

23.4 (17.5–29.4)

34.1 (26.9–41.3)

47.8 (41.3–54.4)

46.8 (40.4–53.2)